TB-500s research base is broader but distributed across the full Thymosin Beta-4 protein literature, with fewer studies using the specific TB-500 synthetic fragment
Heres what may be happening
As of 2026, 5-Amino-1MQ is not approved by any regulatory authority (FDA, EMA, ANSM)
Hebei Junyu Pharmaceutical Co.,Ltd, was established in 1999, which is a professional veterinary medicines company specialized in the R&D, Production, Marketing and Technical Service
Shipping was quick
The limited human data available indicate that both peptides appear to be generally well-tolerated, yet comprehensive safety and efficacy assessments from large, well-designed clinical trials are absent